vs

Side-by-side financial comparison of First Savings Financial Group, Inc. (FSFG) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.

First Savings Financial Group, Inc. is the larger business by last-quarter revenue ($1.5M vs $1.1M, roughly 1.3× Insight Molecular Diagnostics Inc.). First Savings Financial Group, Inc. runs the higher net margin — 350.2% vs -2015.4%, a 2365.6% gap on every dollar of revenue. On growth, First Savings Financial Group, Inc. posted the faster year-over-year revenue change (-0.7% vs -23.4%). First Savings Financial Group, Inc. produced more free cash flow last quarter ($78.3M vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -70.2%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

FSFG vs IMDX — Head-to-Head

Bigger by revenue
FSFG
FSFG
1.3× larger
FSFG
$1.5M
$1.1M
IMDX
Growing faster (revenue YoY)
FSFG
FSFG
+22.7% gap
FSFG
-0.7%
-23.4%
IMDX
Higher net margin
FSFG
FSFG
2365.6% more per $
FSFG
350.2%
-2015.4%
IMDX
More free cash flow
FSFG
FSFG
$85.3M more FCF
FSFG
$78.3M
$-7.0M
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
-70.2%
FSFG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FSFG
FSFG
IMDX
IMDX
Revenue
$1.5M
$1.1M
Net Profit
$5.3M
$-23.0M
Gross Margin
42.5%
Operating Margin
-2057.5%
Net Margin
350.2%
-2015.4%
Revenue YoY
-0.7%
-23.4%
Net Profit YoY
43.5%
31.5%
EPS (diluted)
$0.76
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSFG
FSFG
IMDX
IMDX
Q4 25
$1.1M
Q3 25
$1.5M
$260.0K
Q2 25
$1.4M
$518.0K
Q1 25
$1.5M
$2.1M
Q4 24
$1.5M
$1.5M
Q3 24
$1.5M
$115.0K
Q2 24
$1.4M
$104.0K
Q1 24
$18.0M
$176.0K
Net Profit
FSFG
FSFG
IMDX
IMDX
Q4 25
$-23.0M
Q3 25
$5.3M
$-10.9M
Q2 25
$6.2M
$-9.7M
Q1 25
$5.5M
$-6.7M
Q4 24
$6.2M
$-33.5M
Q3 24
$3.7M
$-13.5M
Q2 24
$4.1M
$-4.5M
Q1 24
$4.9M
$-9.1M
Gross Margin
FSFG
FSFG
IMDX
IMDX
Q4 25
42.5%
Q3 25
53.5%
Q2 25
67.6%
Q1 25
62.0%
Q4 24
40.0%
Q3 24
43.5%
Q2 24
48.1%
Q1 24
25.6%
Operating Margin
FSFG
FSFG
IMDX
IMDX
Q4 25
-2057.5%
Q3 25
-4249.2%
Q2 25
-1900.0%
Q1 25
-318.0%
Q4 24
-2262.9%
Q3 24
-11752.2%
Q2 24
-4453.8%
Q1 24
32.1%
-5265.3%
Net Margin
FSFG
FSFG
IMDX
IMDX
Q4 25
-2015.4%
Q3 25
350.2%
-4174.6%
Q2 25
441.1%
-1880.7%
Q1 25
377.2%
-312.0%
Q4 24
424.0%
-2255.1%
Q3 24
242.4%
-11733.0%
Q2 24
295.8%
-4355.8%
Q1 24
27.3%
-5186.9%
EPS (diluted)
FSFG
FSFG
IMDX
IMDX
Q4 25
$-0.75
Q3 25
$0.76
$-0.34
Q2 25
$0.88
$-0.30
Q1 25
$0.79
$-0.26
Q4 24
$0.89
$-2.19
Q3 24
$0.53
$-0.98
Q2 24
$0.60
$-0.36
Q1 24
$0.72
$-1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSFG
FSFG
IMDX
IMDX
Cash + ST InvestmentsLiquidity on hand
$31.9M
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$193.5M
$-31.5M
Total Assets
$2.4B
$25.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSFG
FSFG
IMDX
IMDX
Q4 25
$11.6M
Q3 25
$31.9M
$18.7M
Q2 25
$52.1M
$24.3M
Q1 25
$28.7M
$31.0M
Q4 24
$76.2M
$8.6M
Q3 24
$52.1M
$3.4M
Q2 24
$42.4M
$9.3M
Q1 24
$63.0M
$5.6M
Stockholders' Equity
FSFG
FSFG
IMDX
IMDX
Q4 25
$-31.5M
Q3 25
$193.5M
$-9.2M
Q2 25
$183.8M
$1.1M
Q1 25
$179.2M
$10.2M
Q4 24
$176.0M
$-12.3M
Q3 24
$177.1M
$9.7M
Q2 24
$168.0M
$22.7M
Q1 24
$165.1M
$11.6M
Total Assets
FSFG
FSFG
IMDX
IMDX
Q4 25
$25.8M
Q3 25
$2.4B
$43.9M
Q2 25
$2.4B
$50.5M
Q1 25
$2.4B
$60.4M
Q4 24
$2.4B
$35.1M
Q3 24
$2.5B
$70.2M
Q2 24
$2.4B
$74.7M
Q1 24
$2.4B
$71.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FSFG
FSFG
IMDX
IMDX
Operating Cash FlowLast quarter
$79.1M
$-5.5M
Free Cash FlowOCF − Capex
$78.3M
$-7.0M
FCF MarginFCF / Revenue
5199.5%
-616.7%
Capex IntensityCapex / Revenue
58.4%
129.9%
Cash ConversionOCF / Net Profit
15.01×
TTM Free Cash FlowTrailing 4 quarters
$51.4M
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FSFG
FSFG
IMDX
IMDX
Q4 25
$-5.5M
Q3 25
$79.1M
$-4.5M
Q2 25
$6.5M
$-6.3M
Q1 25
$-32.8M
$-5.9M
Q4 24
$177.0K
$-5.4M
Q3 24
$91.2M
$-5.5M
Q2 24
$-655.0K
$-6.0M
Q1 24
$7.7M
$-3.8M
Free Cash Flow
FSFG
FSFG
IMDX
IMDX
Q4 25
$-7.0M
Q3 25
$78.3M
$-5.6M
Q2 25
$6.5M
$-6.6M
Q1 25
$-32.9M
$-6.2M
Q4 24
$-347.0K
$-5.6M
Q3 24
$90.5M
$-5.6M
Q2 24
$-702.0K
$-6.2M
Q1 24
$7.7M
$-3.9M
FCF Margin
FSFG
FSFG
IMDX
IMDX
Q4 25
-616.7%
Q3 25
5199.5%
-2135.4%
Q2 25
462.7%
-1279.5%
Q1 25
-2258.8%
-288.4%
Q4 24
-23.6%
-374.5%
Q3 24
5974.9%
-4884.3%
Q2 24
-51.0%
-5931.7%
Q1 24
42.6%
-2189.8%
Capex Intensity
FSFG
FSFG
IMDX
IMDX
Q4 25
129.9%
Q3 25
58.4%
403.8%
Q2 25
0.5%
67.4%
Q1 25
8.7%
14.4%
Q4 24
35.7%
14.4%
Q3 24
45.1%
75.7%
Q2 24
3.4%
183.7%
Q1 24
0.0%
13.6%
Cash Conversion
FSFG
FSFG
IMDX
IMDX
Q4 25
Q3 25
15.01×
Q2 25
1.05×
Q1 25
-5.97×
Q4 24
0.03×
Q3 24
24.84×
Q2 24
-0.16×
Q1 24
1.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons